Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults
9/18/2015
Business related Regulatory Marketing authorization application granted Central Nervous System PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR API - CARIPRAZINE